Inactive Instrument

Sector Chart Melinta Therapeutics Inc Nasdaq

Equities

US58549G1004

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
122B
113B
22.66B -
21.34B -
16.92B